Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts

Kidney International

Volumn 52, Issue 6, 1997, Pages 1497-1510

  Ruiz ortega, Marta ^a   Egido, Jesús ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Fund Jiménez Díaz   (Spain)

Author keywords

Angiotensin II; Cell growth; Renal fibrosis; Renal interstitial fibroblasts

Indexed keywords

ANGIOTENSIN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL GROWTH; CELL PROLIFERATION; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FIBROBLAST; LEYDIG CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0031452519     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.480     Document Type: Article

References (76)

1. WIGGINS R, GOYAL M, MERRITT S, KILLEN PD: Vascular adventitial cell expression of collagen type 1 messenger ribonucleic acid in antiglomerular membrane antibody-induced crescentic nephritis in rabbit. Lab Invest 68:557-565, 1993
2. STRUZT F: Novel aspects of renal fibrogenesis. Nephrol Dial Transplant 10:1526-1532, 1995
3. KUNCIO GS, NEILSON EG, HAVERTY T: Mechanisms of tubulointerstitial fibrosis. Kidney Int 39:550-556, 1991
4. GONZÁLES-CUADRADO S, BUSTOS C, RUIZ-ORTEGA M, ORTIZ A, GUIJARRO C, PLAZA JJ, EGIDO J: Expression of leukocyte chemoattractants by interstitial renal fibroblasts: Up-regulation by drugs associated with interstitial fibrosis. Clin Exp Immunol 106:518-522, 1996
5. KLAHR S, SCHREINER G, ICHIKAWA I: The progression of renal disease. N Engl J Med 318:1657-1666, 1988
6. BRUNNER HR: ACE inhibitors in renal disease. Kidney Int 42:463-479, 1992
7. EGIDO J: Vasoactive hormones and renal sclerosis. (Nephrology Forum) Kidney Int 49:578-597, 1996
8. DIAMOND JR, ANDERSON S: Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis, amelioration by angiotensin I converting enzyme inhibition. Am J Pathol 137:1323-1331, 1990
9. KANETO H, MORRISSEY J, MCCRACKEN R, REYES A, KLAHR S: Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int 45:1637-1647, 1994
10. ISHIDOYA S, MORRISSEY J, MCCRACKEN R, REYES A, KLAHR S: Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 47:1285-1294, 1995
11. RUIZ-ORTEGA M, GONZÁLES S, SERON D, CONDOM E, BUSTOS C, LARGO R, GONZÁLES E. EGIDO J: ACE inhibition reduces protein-uria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis. Kidney Int 48:1778-1791, 1995
12. WU LL, COX A, ROE CJ, DZIADEK M, COOPER ME, GILBERT RE: Transforming growth factor β1 and renal injury following subtotal nephrectomy in the rat: Role of the renin-angiotensin system. Kidney Int 51:1555-1567, 1997
13. MICHEL B, GRIMA M, STEPHAN D, COQUARD C, WELSCH C, BARTHELMEBS M, IMBS JL: Plasma and renin activity and changes in tissue angiotensin converting enzyme. J Hypertens 12:577-584, 1994
14. PIMENTEL JL, MONTERO A, WANG S, YOSIPIV I, ELDAHR S, MARTINEZ-MALDONADO M: Sequential changes in renal expression of renin angiotensin system genes in acute unilateral ureteral obstruction. Kidney Int 48:1247-1253, 1995
15. RUIZ-ORTEGA M, DUQUE, N, GÓMEZ-GUERRERO C, EGIDO J: Upregulation and redistribution of renin angiotensin system genes in the kidney of normotensive rats with immune complex nephritis, (abstract) J Am Soc Nephrol 7:1745, 1996
16. JOHNSON RJ, ALPERS CE, YOSHIMURA A, LOMBARDI D, PRITZI, P, FLOEGE J, SCHWARTZ SM: Renal injury from angiotensin II-mediated hypertension. Hypertension 19:464-474, 1992
17. MAI M, GEIGER H, HILGERS KF, VEELKEN R, MANN JFE, DÄMMRICH J, LUFT F: Early interstitial changes in hypertension-induced renal injury. Hypertension 22:754-765, 1993
18. WOLF G, NEILSON EG: Angiotensin II as a renal growth factor. J Am Soc Nephrol 3:1531-1540, 1993
19. SHARMA K, ZIYADEH FN: The emerging role of transforming growth-beta and extracellular matrix in kidney diseases. Am J Physiol 266: F829-F842, 1994
20. BORDER WA, ROUSLAHTI E: Transforming growth factor-β in disease: The dark side of tissue repair. J Clin Invest 90:1-7, 1992
21. QUIRÓS J, GONZÁLEZ-CABRERO J, EGIDO J, HERRERO-BEAUMONT G, MARTÍNEZ MONTERO CG: Beneficial effect of fibronectin administration on chronic nephritis in rats. Arthritis Rheum 33:685-692, 1990
22. SMITH RD, CHUI AT, WONG PC, HERBLIN W, TIMMERMANS PB-MWM: Pharmacology of nonpeptide angiotensin II receptor antagonists. Annu Rev Pharmacol Toxicol 32:135-65, 1992
23. 2+ mobilization in rat and human mesangial cells. J Immunol 156:4369-4376, 1996
24. HEDLEY DW, FRIEDLANDER ML, TAYLOR IW, RUGG CA, MUSGROVE EA: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 31:1333-1335, 1983
25. OLIVER MH, HARRISON NK, BISHOP JE, COLE PJ, LAURENT GJ: A rapid and convenient assay for counting cells cultured in microwell plates: Application for assessment of growth factors. J Cell Scien 92:513-518, 1989
26. CHOMAZYNSKI P, SACCHI N: Single-step of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
27. RUIZ-ORTEGA M, LARGO R, BUSTOS C, GÓMEZ-GARRE D, EGIDO J: Platelet activating factor stimulates gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells. Role of transforming growth factor-β. J Am Soc Nephrol 8:1266-1275, 1997
28. MURPHY TT, ALEXANDER RW, GRIENDLING KK, RUNGE MS, BERNSTEIN KE: Isolation of cDNA encoding the vascular type-I angiotensin receptor. Nature (London) 351:233-236, 1991
29. DOSTAL DE, ROTHBLUM KN, CHERNIN MI, COOPER GR, BAKER KM: Intracardiac detection of angiotensinogen and renin: A localized renin-angiotensin system in neonatal rat heart. Am. J Physiol 32:C838-C850, 1992
30. FORT P, MARTY L, PIEZCHACZYK M, SABROUTY SE, DANI C, JEAN-TEUR P, BLANCHARD JM: Various rat adult tissues express only one mayor mRNA especies from glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucl Acid Res 13:1431-1442, 1985
31. TAKASAKI I, CHOBANIAN AV, BRECHER P: Biosynthesis of fibronectins by rabbit aorta. J Biol Chem 266:17686-17694, 1991
32. YAMAGUCHI Y: The structure and function of renal interstitial cells. Nippon Rinsho 53:1841-1845, 1995
33. FONTOURA BMA, NUSSENZVEIG DR, TIMMERMANS PBMWM, MAACK T: Dup753 is a potent nonpeptide antagonist of angiotensin II receptors in isolated perfused rat kidney and in cultured renal cells. Am J Hypertens 4:S303-S308, 1991
34. ALVAREZ RJ, SUN MJ, HAVERTY TP, IOZZO RV, MYERS JC, NEILSON EG: Biosynthetic and proliferative characteristics of tubulointerstitial fibroblast probed with paracrine cytokines. Kidney Int 41:14-23, 1992
35. VILLAREAL FJ, KIM NN, UNGAB GD, PRINTZ MP, DILLMANN WH: Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 88:2849-2861, 1993
36. CRABOS M, ROTH M, HAHN AW, ERNE P: Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression. J Clin Invest 93:2372-2378, 1994
37. JOHNSON MC, AGUILERA G: Angiotensin II receptors subtypes and coupling to signaling systems in cultured fibroblasts. Endocrinology 129:1266-1274, 1991
38. WHITEBREAD S, MELE M, KAMBER B, DE GASPARO M: Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun 163:284-291, 1984
39. CHANSEL D, CZEKALSKI S, PHAM P, ARDAILLOU R: Characterization of angiotensin II receptor subtypes in human glomeruli and mesangial cells. Am J Physiol 262:F432-F441, 1992
40. MENÉ P, SIMONSON MS, DUNN MJ: Physiology of the mesangial cell. Physiol Rev 69:1347-1424, 1989
41. WOLF G, NEILSON EG: Angiotensin II as a hypertrophogenic cytokine for proximal tubular cells. Kidney Int 43(Suppl 39):S100-S107, 1993
42. GRIEDLING KK, USHIO-FUKAI M, LASSÈGUE B, ALEXANDER RW: Angiotensin II signaling in vascular smooth muscle cells. Hypertension 29:366-373, 1997
43. BERK BC, CORSON MA: Angiotensin II signal transduction in vascular smooth muscle. Role of tyrosine kinases. Circ Res 80:607-616, 1997
44. VERMA IM, SASSONE-CORSI J: Proto-oncogene fos: Complex but versatile regulation. Cell 51:513-514, 1987
45. RAUSCHER FJ, COHEN DR, CURRAN T. BOS TJ, VOGT PK, BOHMAS D, TJIAN R, FRANZA BR: Fos-associated protein p39 is the product of the jun protooncogen. Science (Wash DC) 240:1010-1016, 1988
46. ROSENBERG ME, HOSTETTER TH, KREN S, CHMIELEWSKI D: In vivo effect of angiotensin II and norepinephrine on early growth response genes in the rat kidney. Kidney Int 43:601-609, 1993
47. BRILLA CG, ZHOU G, MATSUBARA L, WEBER KT: Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone. J Mol Cell Cardiol 26:809-820, 1994
48. STUDER RK, NEGRETE H, CRAVEN PA, DERUBERTIS FR: Protein kinase C signals thromboxane induced increases in fibronectin synthesis and TGF-β bioactivity in mesangial cells. Kidney Int 48:422-430, 1995
49. NAKAMURA A, IWAO H, FUKUI K, KIMURA S, TAMAKI T, NAKANISHI S, ABE Y: Regulation of liver angiotensinogen and kidney renin mRNA levels by angiotensin II. Am J Physiol 258:E1-E6, 1990
50. SADOSHIMA J, IZUMO S: Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 73:413-423, 1993
51. BERNSTEIN KE, BERK BC: The biology of angiotensin II receptors. Am J Kidney Dis 22:745-754, 1993
52. DZAU VJ, MUKOYAMA M, PRATT RE: Molecular biology of angiotensin receptors: Target for drug research? J Hypertens 12:S1-S5, 1994
53. YAMADA T, HORIUCHI M, DZAU VJ: Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA 93:156-160, 1996
54. 2 receptor subtypes in vascular trophic and phenotypic changes in response to stimulation with angiotensin II. Arterioscler Thromb Vasc Biol 17:257-264, 1997
55. 2 receptors. (abstract) J Am Soc Nephrol 7:1725, 1996
56. RUIZ-ORTEGA M, LORENZO O, EGIDO J: The angiotensin (Ang) degradation product. AngIII, activates nuclear transcription factor κB (NF-κB) and increases gene expression in renal cells. (abstract) J Am Soc Nephrol 8:506A, 1997
57. LO M, LIU KL, LANTELME P, SASSARD J: Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats. J Clin Invest 95:1394-1397, 1995
58. JANIAK P, PILLON A, PROST JF, VILAINE JP: Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension 20:737-745, 1992
59. MILLAN MA, CARVALLO P, IZUMI SI, ZEMEL S, CATT KJ, AGUILERA G: Novel sites of expression of functional angiotensin II receptors in the late gestation fetus. Science 244:1340-1342, 1989
60. JOHNSON MC, AGUILERA G: Studies on the mechanism of the novel stimulatory effect of angiotensin-II on Adenylate cyclase in rat fetal skin fibroblast. Endocrinology 131:2402-2412, 1992
61. GÓMEZ-GARRE D, RUIZ-ORTEGA M, ORTEGO M, LÓPEZ-ARMADA MJ, LARGO R, PLAZA JJ, GONZÁLEZ E, EGIDO J: Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. Hypertension 27:885-892, 1996
62. RODEMANN HP, MÜLLLR GA: Characterization of human renal fibroblast in health and disease, II: In vitro growth, differentiation, and collagen synthesis of fibroblast from kidneys with interstitial fibrosis. Am J Kidney Dis 17:684-686, 1991
63. RUIZ-ORTEGA M, GÓMEZ-GARRE D, ALCAZAR R, PALACIOS I, BUSTOS C, GONZÁLEZ, S, GONZÁLEZ E, PLAZA JJ, EGIDO J: Involvement of angiotensin II and endothelin on matrix protein production and renal sclerosis. J Hypertens 12:S51-S58, 1994
64. KAGAMI S, BORDER WA, MILLER DE, NOBLE NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
65. NISHIZUKA Y: The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature (Lond) 308:693-698, 1984
66. MARRERO MB, PAXTON WG, DUFF JL, BERK BC, BERNSTEIN KE: Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-gamma-1 in vascular smooth muscle cells. J Biol Chem 269:10935-10939, 1994
67. MARRERO MB, SCHIEFFER B, PAXTON WG, HEERDT L, BERK BC, DELAFONTAINE P, BERNSTEIN KE: Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 375:247-250, 1995
68. HOLLENBERG, MD: Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol Sci 15:108-114, 1994
69. LEDUC I, HADDAD P, GIASSON E, MELOCHE S: Involvement of a tyrosine kinase pathway in the growth-promoting effects of angiotensin II on aortic smooth muscle cells. Mol Pharmacol 48:582-592, 1995
70. DOSTAL DE, ROTHBLUM KN, CONRAD KM, COOPER GR, BAKER KM: Detection of angiotensin I and II in cultured cardiac myocytes and fibroblasts. Am J Physiol 263:C851-C863, 1992
71. EGGENA P, ZHU JH, CLEGG F, BARRET JD: Nuclear angiotensin receptors induce transcription of renin and angiotensinogen mRNA. Hypertension 22:496-501, 1993
72. BRASIER AR, LI J: Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension 27:465-475, 1996
73. LIAO F, ANDALIBI A, DEBEER FC, FOGELMAN AM, LUSIS AJ: Genetic control of inflammatory gene induction and NF-κB-like transcription factor activation in response to atherogenic diet in mice. J Clin Invest 91:2572-2579, 1993
74. KAGEYAMA R, OKUBO H, NAKANISHI S: Induction of rat liver angiotensinogen mRNA following acute inflammation. Bioche Biophys Res Commun 129:826-832, 1985
75. RUIZ-ORTEGA M, BUSTOS C, GONZÁLEZ-CUADRADO S, HERNÁNDEZ-PRESA MA, EGIDO J: Angiotensin II participates in mononuclear cell recruitment in the kidney through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 gene expression. (abstract) J Am Soc Nephrol 7:1718, 1996
76. HERNÁNDEZ-PRESA MH, BUSTOS C, ORTEGO M. TUÑÓN J, RENEDO G, RUIZ-ORTEGA M, EGIDO J: Angiotensin converting enzyme inhibition prevents arterial NFκB activation. MCP-1 expression and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 95:1532-1541, 1997